UK: Another Delay To VPAG Deadline For Pharma As Global Uncertainty Continues

 
• By Eliza Slawther
  
Pharma firms in the UK have more time to consider whether to opt-out of the UK voluntary pricing scheme (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from United Kingdom

More from Europe